Hemab Therapeutics Announces First Healthy Volunteer Dosed In Phase 1 Trial Of HMB-003 For Heavy Menstrual Bleeding; Says Results Expected No Later Than Mid-2027

뉴스 본문을 불러오고 있어요.

Hemab Therapeutics Announces First Healthy Volunteer Dosed In Phase 1 Trial Of HMB-003 For Heavy Menstrual Bleeding; Says Results Expected No Later Than Mid-2027 | 웨이프 WAPE

Hemab Therapeutics Announces First Healthy Volunteer Dosed In Phase 1 Trial Of HMB-003 For Heavy Menstrual Bleeding; Says Results Expected No Later Than Mid-2027

기사 요약

관련 종목

댓글 —